Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rapid Response System”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Post-approval studies (Phase 4)Study completedNCT00502099
What this trial is testing

Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4

Who this might be right for
Hepatitis C
Amr Hafez 217
Not applicableStudy completedNCT01464008
What this trial is testing

The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Beijing Ditan Hospital 297
Large-scale testing (Phase 3)Study completedNCT00623428
What this trial is testing

Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 235
Not applicableStudy completedNCT06238128
What this trial is testing

Opioid Rapid Response System: Naloxone Training in Communities

Who this might be right for
Opioid Overdose
University of Missouri-Columbia 773
Testing effectiveness (Phase 2)Study completedNCT01353248
What this trial is testing

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 141
Not applicableNot Yet RecruitingNCT07781215
What this trial is testing

E-nose in Evaluating Colitis Activity

Who this might be right for
IBD (Inflammatory Bowel Disease)
Tampere University Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00743795
What this trial is testing

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Who this might be right for
HCV Infection
Gilead Sciences 252
Testing effectiveness (Phase 2)Study completedNCT02643641
What this trial is testing

Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response

Who this might be right for
Hypersensitivity
Biomay AG 130
Not applicableStudy completedNCT02524925
What this trial is testing

Postoperative Stress Response in Patients Following Fast Track vs Conventional Protocol After Hepatectomy or Pancreatectomy

Who this might be right for
Hepatic CancerCancer of Pancreas
National and Kapodistrian University of Athens 231
Not applicableStudy completedNCT02754947
What this trial is testing

Need for the Assessment and Consultation Team (ACT) Following Anesthetic Care

Who this might be right for
Cardiovascular DiseasesRespiratory DiseasesNeurologic Diseases
Nationwide Children's Hospital 100
Post-approval studies (Phase 4)Looking for participantsNCT07611214
What this trial is testing

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 150
Not applicableStudy completedNCT04677153
What this trial is testing

Rapid HCV Treatment Access for Persons Who Use Drugs

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
Johns Hopkins University 198
Not applicableLooking for participantsNCT06965101
What this trial is testing

To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway

Who this might be right for
Metastatic Spinal Cord Compression
The Christie NHS Foundation Trust 72
Post-approval studies (Phase 4)UnknownNCT01683786
What this trial is testing

36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8

Who this might be right for
Hepatitis C Infection
Chang Gung Memorial Hospital 60
Not applicableStudy completedNCT06141395
What this trial is testing

NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification

Who this might be right for
PneumoniaAcute PyelonephritisBacteremia+1 more
Hellenic Institute for the Study of Sepsis 100
Testing effectiveness (Phase 2)Ended earlyNCT00305383
What this trial is testing

Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Bausch Health Americas, Inc. 100
Not applicableLooking for participantsNCT07775235
What this trial is testing

Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseMyositis
Singapore General Hospital 80
Not applicableStudy completedNCT06815718
What this trial is testing

Observational Study Evaluating the viQtor for Early Detection of Clinical Deterioration in Post-ICU Patients on General Wards

Who this might be right for
Early Warning ScoreMonitoringTelemedicine-Based Education+2 more
Erasmus Medical Center 180
Large-scale testing (Phase 3)Study completedNCT00758043
What this trial is testing

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 540
Next Page